Match each clinical presentation of infective endocarditis with the most appropriate targeted antimicrobial regimen based on current consensus guidelines.
- A 45-year-old man with native valve infective endocarditis caused by Enterococcus faecalis.Intravenous ampicillin and ceftriaxone
- A 65-year-old man with prosthetic valve endocarditis diagnosed 3 months after valve replacement, caused by methicillin-resistant Staphylococcus epidermidis.Intravenous vancomycin, rifampin, and gentamicin
- A 30-year-old woman with a history of injection drug use presenting with right-sided native valve endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA).Intravenous nafcillin or cefazolin
- A 72-year-old man with native valve endocarditis caused by highly penicillin-susceptible Streptococcus gallolyticus (S. bovis).Intravenous aqueous crystalline penicillin G or ceftriaxone
Cevap
Enterococcus faecalis is matched with ampicillin and ceftriaxone; methicillin-resistant Staphylococcus epidermidis on a prosthetic valve is matched with vancomycin, rifampin, and gentamicin; methicillin-susceptible Staphylococcus aureus is matched with nafcillin or cefazolin; and Streptococcus gallolyticus is matched with aqueous crystalline penicillin G or ceftriaxone.
Each pathogen and valve combination has a highly specific guideline-directed regimen designed to optimize bactericidal activity, minimize toxicity, and penetrate biofilms when foreign material is present.
Adım Adım Çözüm
Anahtar Kavram
Targeted antimicrobial therapy for infective endocarditis is determined by the specific pathogen, resistance profile, and presence of native versus prosthetic valves.
Tahmini Süre:1m 30s